MULTI-TARGET MODULATION FOR TREATING FIBROSIS AND INFLAMMATORY CONDITIONS
    5.
    发明申请
    MULTI-TARGET MODULATION FOR TREATING FIBROSIS AND INFLAMMATORY CONDITIONS 审中-公开
    用于治疗纤维化和炎症条件的多目标调节

    公开(公告)号:US20150080320A1

    公开(公告)日:2015-03-19

    申请号:US14399909

    申请日:2013-05-14

    申请人: AADIGEN, LLC

    发明人: Neil Desai

    IPC分类号: C12N15/113 A61K47/48

    摘要: The present invention relates to compositions comprising one or more active agents that selectively modulate the expression of two or more genes, for example at the post-transcription level, that are involved in fibrosis and/or inflammatory conditions. Also provided are methods of using such compositions for treating fibrotic diseases, as well as other diseases including inflammatory diseases and cancer.

    摘要翻译: 本发明涉及包含一种或多种选择性调节参与纤维化和/或炎性病症的两个或更多个基因(例如在转录后水平)的表达的活性剂的组合物。 还提供了使用这种组合物治疗纤维化疾病以及其它疾病(包括炎性疾病和癌症)的方法。

    COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS

    公开(公告)号:US20230304010A1

    公开(公告)日:2023-09-28

    申请号:US18017644

    申请日:2021-07-23

    申请人: AADIGEN, LLC

    IPC分类号: C12N15/113 A61P31/14

    摘要: The present application provides peptides and nucleic acids that are useful for treating virus (e.g., SARS-CoV-2) infection. Exemplary peptides comprise chimeric peptides and blocking peptides that block the interaction between SPIKE and ACE2. Exemplary nucleic acids include siRNAs that specifically target SARS-CoV-2. The present applications also provide complexes and nanoparticles further comprising a second peptide (e.g., a cell-penetrating peptide) that promotes intracellular delivery of the peptides and nucleic acids.

    PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MOLECULES

    公开(公告)号:US20220313825A1

    公开(公告)日:2022-10-06

    申请号:US17594454

    申请日:2020-04-16

    申请人: AADIGEN, LLC

    摘要: The present application is directed to cargo delivery complexes for intracellular delivery of a cargo molecule comprising: a first peptide comprising a cell-penetrating peptide (CPP), a second peptide comprising a cell-penetrating peptide, and a cargo molecule. The second peptide comprises a polyethylene glycol (PEG) moiety linked to the second CPP, and the first peptide does not have a PEG moiety. The present application is also directed to a cargo delivery complex comprising a CPP and a cargo molecule wherein the CPP is a retro-inverso peptide. The present application is also directed to a cargo delivery complex comprising a CPP and a cargo molecule wherein the peptide further comprises a targeting sequence selected from the group consisting of GYVSK, GYVS, YIGS and YIGSR. Methods of making and using the cargo delivery complexes are also disclosed.